Litecoin Hits 5-Month High on $100M MEI Pharma Investment and ETF Hopes

Litecoin has gained significant momentum in early August 2025, reaching a five-month high of $128.40, driven primarily by MEI Pharma’s $100 million treasury investment and ongoing speculation about potential ETF approval. The corporate buy-in is being positioned as a key catalyst for the price rally, surpassing the impact of ETF-related optimism according to some analysts [1]. MEI Pharma’s strategic shift into a Litecoin treasury firm through a private placement highlights a growing trend of institutional interest in the cryptocurrency, signaling long-term confidence in its value [2].

The surge has pushed Litecoin’s price higher by over 41% in the month of July, with its market capitalization climbing to $9.4 billion [3]. This growth is complemented by Litecoin’s expanding use in real-world payments. According to CoinGate, Litecoin captured 14.5% of crypto payments last month, securing the second-highest share after Bitcoin’s 22.9% [4]. The increasing adoption by merchants reinforces its utility and positions Litecoin as a leading digital currency in the payments space.

Decentralized prediction markets estimate an 80% probability of a Litecoin ETF being approved in 2025 [5]. While these projections fuel optimism, analysts note that ETF expectations have been in place since early 2025, making MEI Pharma’s corporate treasury investment the more immediate and impactful driver of Litecoin’s price action [6]. The growing institutional adoption, combined with a strengthening payment infrastructure, could further solidify Litecoin’s market position and attract more investors.

Corporate treasury investments like MEI Pharma’s are seen as a potential turning point for Litecoin, reflecting a broader trend of companies converting into crypto-focused investment vehicles. This development may encourage more institutional and corporate actors to explore Litecoin as a strategic asset, potentially increasing demand and stabilizing its value over time [7]. Investors are advised to monitor both institutional investment trends and ETF-related regulatory developments for future market opportunities [8].

Litecoin’s current performance underscores the convergence of corporate adoption and speculative momentum, with its price rising 5.8% in the last 24 hours and 12.3% over the past week [9]. As corporate confidence in crypto continues to rise, Litecoin is well-positioned to maintain its upward trajectory, provided it sustains both its utility in payments and favorable regulatory developments.

Source:

[1] title1: Litecoin Gains Momentum Amid ETF Speculation and MEI Pharma’s Corporate Treasury Investment

https://en.coinotag.com/litecoin-gains-momentum-amid-etf-speculation-and-mei-pharmas-corporate-treasury-investment/

[2] title2: Litecoin Gains Momentum Amid ETF Speculation and MEI Pharma’s Corporate Treasury Investment

[3] title3: Litecoin Gains Momentum Amid ETF Speculation and MEI Pharma’s Corporate Treasury Investment

[4] title4: Litecoin Gains Momentum Amid ETF Speculation and MEI Pharma’s Corporate Treasury Investment

[5] title5: Litecoin Gains Momentum Amid ETF Speculation and MEI Pharma’s Corporate Treasury Investment

[6] title6: Litecoin Gains Momentum Amid ETF Speculation and MEI Pharma’s Corporate Treasury Investment

[7] title7: Litecoin Gains Momentum Amid ETF Speculation and MEI Pharma’s Corporate Treasury Investment

[8] title8: Litecoin Gains Momentum Amid ETF Speculation and MEI Pharma’s Corporate Treasury Investment

[9] title9: Litecoin Gains Momentum Amid ETF Speculation and MEI Pharma’s Corporate Treasury Investment